Neena M Patil Executes Sell Order: Offloads $456K In Jazz Pharmaceuticals Stock
Disclosed on November 13, Neena M Patil, EVP & Chief Legal Officer at Jazz Pharmaceuticals JAZZ -2.13% Get Free Report , ...
GlobalData on MSN21h
Syndax’s stock sinks by 25% despite AML trial meeting primary endpoint
Despite this success, investors were unimpressed with the topline data, with Syndax’s stock dropping by 25.6%, from $21.78 ...
Oncology Nurse Advisor23h
HSCT Bests Non-HSCT Consolidation in Older AML Patients
Hematopoietic stem cell transplant (HSCT) after first complete remission appears more effective than non-HSCT consolidation in older patients with AML.
Le Lézard1h
Flatiron Health announces research to be presented at American Society of Hematology Annual Meeting and Exposition
Flatiron Health today announced their planned presence at the American Society of Hematology (ASH) Annual Meeting and Exposition, including seven accepted abstracts for poster presentation and ...
TriSalus Life Sciences, Inc. (TLSI) Q3 2024 Earnings Call Transcript
TriSalus Life Sciences, Inc. ( NASDAQ: TLSI) Q3 2024 Earnings Conference Call November 14, 2024 9:00 AM ET Jim Young - Senior Vice President, Investor Relations & Treasurer Mary Szela - President & ...
Targeted Oncology15h
Balancing Clinical Data and Real-World Insights in CML Treatment
In an interview with Targeted Oncology, Michael Mauro, MD, delved into the rapidly advancing field of chronic myeloid ...
Le Lézard2h
Curis Provides Third Quarter 2024 Business Update
Curis, Inc. ("Curis") , a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today reported its business update and ...